New Strategies and Combinations to Improve Outcomes in Immunotherapy in Metastatic Non-Small-Cell Lung Cancer

Immune checkpoint inhibitors have transformed the treatment of metastatic non-small-cell lung cancer, yielding marked improvements in survival and the potential for durable clinical responses. Primary and acquired resistance to current immune checkpoint inhibitors constitute a key challenge despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Corke, Lucy, Sacher, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774728/
https://www.ncbi.nlm.nih.gov/pubmed/35049678
http://dx.doi.org/10.3390/curroncol29010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774728/
https://www.ncbi.nlm.nih.gov/pubmed/35049678
http://dx.doi.org/10.3390/curroncol29010004

Ejemplares similares